UBS Starts Sun Healthcare Group (SUNH) at Neutral; Leading Operator with Reimbursement Concerns
Tweet Send to a FriendGet Alerts SUNH Hot Sheet
Price: $8.51 --0%
Rating Summary:
0 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 7 | New: 16
Rating Summary:
0 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 7 | New: 16
Trade SUNH Now!
UBS initiates coverage on Sun Healthcare Group (NASDAQ: SUNH) with a Neutral. PT $8.50.
Analyst, A.J. Rice, said, "SUNH's recent amendment to its credit agreement offers greater cushion on its leverage covenants. The company paid down $50 million of debt and increased the interest rate by 1.25% on the remaining debt in order to receive relief on its maximum leverage and interest coverage covenants. However, potential Medicare and Medicaid reimbursement changes have been the biggest source of share price volatility for post-acute care providers."
For an analyst ratings summary and ratings history on Sun Healthcare Group click here. For more ratings news on Sun Healthcare Group click here.
Shares of Sun Healthcare Group closed at $8.35 yesterday, with a 52 week range of $2.06-$8.77.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, A.J. Rice, said, "SUNH's recent amendment to its credit agreement offers greater cushion on its leverage covenants. The company paid down $50 million of debt and increased the interest rate by 1.25% on the remaining debt in order to receive relief on its maximum leverage and interest coverage covenants. However, potential Medicare and Medicaid reimbursement changes have been the biggest source of share price volatility for post-acute care providers."
For an analyst ratings summary and ratings history on Sun Healthcare Group click here. For more ratings news on Sun Healthcare Group click here.
Shares of Sun Healthcare Group closed at $8.35 yesterday, with a 52 week range of $2.06-$8.77.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Starts Insmed (INSM) at Buy
- JMP Securities Starts Gramercy Property Trust (GPT) at Market Outperform
- UPDATE: Keryx Biopharma (KERX) Patents Strong; JPMorgan Starts at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
UBSLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

